Frequently asked questions — Interpretation of plasma glucose and OGTT
1) When should prediabetes be suspected?
Prediabetes should be suspected when fasting plasma glucose is between 100–125 mg/dL (impaired fasting glucose) and/or when 2-hour plasma glucose after OGTT is between 140–199 mg/dL (impaired glucose tolerance). These values do not confirm diabetes, but identify an increased risk of progression and indicate the need for lifestyle intervention.
2) When is it mandatory to repeat the test to confirm diabetes?
Whenever the value is in the diagnostic range for diabetes (fasting ≥126 mg/dL or 2-hour ≥200 mg/dL), the test must be repeated on another day for confirmation — except when classic symptoms of hyperglycaemia are present, such as polyuria, polydipsia and unexplained weight loss.
3) Which symptoms make repeat testing unnecessary?
In the presence of clear signs and symptoms of hyperglycaemia (polyuria, polydipsia, weight loss), a single value in the diabetic range is sufficient to confirm the diagnosis, without the need for repeat testing.
4) Which test should be repeated for confirmation?
Confirmation should be performed using the same method (e.g. OGTT → OGTT; fasting glucose → fasting glucose), under similar conditions (adequate fasting, same analytical method). HbA1c may be used as an alternative test if the laboratory method is adequately standardized.
5) Do values in the prediabetes range require repeat testing?
No. Values in the prediabetes range (fasting 100–125 or 2-hour 140–199) do not require repeat testing for confirmation. They are sufficient to classify risk and recommend lifestyle changes, screening for cardiovascular risk factors and clinical follow-up.
6) What is the role of the OGTT?
The OGTT is more sensitive for detecting impaired glucose tolerance and should be used when fasting glucose is borderline, in high-risk patients (obesity, PCOS, family history, cardiovascular disease) and when postprandial dysglycaemia is suspected.
7) Can HbA1c replace fasting glucose and OGTT?
HbA1c may be used for diagnosis when the method is standardized (NGSP/DCCT) and there are no haematological interfering factors. Prediabetes is defined between 5.7–6.4% and diabetes at ≥6.5%. It may be less sensitive in early stages or in specific populations (PCOS, >65 years, obesity).
8) Which patients should be screened even without symptoms?
Screening is recommended in adults aged ≥35 years, or earlier in the presence of risk factors: increased BMI, family history, dyslipidaemia, hypertension, PCOS, sedentary lifestyle, history of prediabetes or gestational diabetes.